George J. Netto MD

Introducing Precision Pathology Podcast! ⁦⁦@ESP_Pathology⁩ ⁦⁦@TheUSCAP⁩ ⁦⁦@ASCO⁩ ⁦⁦@Nature⁩ ⁦⁦@CellCellPress⁩ ⁦⁦@ScienceMagazine⁩ ⁦@PennMedicine⁩ ⁦@PennPathLabMed⁩ ⁦@Pathologists⁩ podcasts.apple.com/us/podcast/pre…

Immune cells from the gut drive development of Parkinson’s disease in the brain nature.com/articles/d4158…

Please join us at our annual alumni and friends reception at @TheUSCAP 2026 annual meeting You're Invited: March 23, Alumni Reception during USCAP t.e2ma.net/share/inbound/…

Congratulations to our remarkable faculty, trainees, and staff at Penn Pathology and Laboratory Medicine on the distinguished honor of being ranked the #1 Department of Pathology in The National Institutes of Health (NIH) Funding for three years in a row! @PennPathLabMed @PennMedicine @PennMedCSO @ASCP_Chicago @TheUSCAP @ESP_Pathology @Pathologists

New Episode of Precision Pathology Podcast! A great conversation with ⁦@sydshaffer⁩ . ⁦@PennMedicine⁩ ⁦@PennPathLabMed⁩ ⁦@Penn⁩ ⁦@ESP_Pathology⁩ ⁦@TheUSCAP⁩ podcasts.apple.com/us/podcast/pre…

May the coming year be prosperous peaceful and most rewarding to all the friends and colleagues🎊🎆

Revolutionizing CNS Tumor Diagnostics: Intraoperative Methylation Profiling! Join me as I discuss with Professor Felix Sahm, from @uniklinik_hd University of Heidelberg, his team's innovative multi-center study on intraoperative molecular profiling of CNS tumors. Learn how rapid methylation profiling could change the landscape of diagnostics and management of brain neoplasms. @ESP_Pathology @TheUSCAP @ASCP_Chicago @PennPathLabMed #CNS #BrainTumors #MolecularProfiling #MethylationProfiling #PrecisionMedicine #ArtificialIntelligence pathology.med.upenn.edu/precision-path…" target="_blank" >Revolutionizing CNS Tumor Diagnostics: Intraoperative Methylation Profiling!

The Vodcast is out! An enjoyable discussion with Dr. Matija Snuderl A Second Look at the Impact of TERTp Mutation on Meningioma Grade pathology.med.upenn.edu/precision-path… @nyulangone @nyuniversity @ESP_Pathology @TheUSCAP @ASCP_Chicago @IARCWHO @PennMedicine @PennPathLabMed A Second Look at the Impact of TERTp Mutation on Meningioma Grade youtu.be/iURpr7eHSfg?si… via @YouTube

Ice cream social with some of our Penn fellows!! Happy Holidays everyone!! ⁦@PennPathLabMed⁩ ⁦@DrNetto⁩ ⁦@ktmontone⁩ #pathology #PathX #pathologyfellowship

We are thrilled to welcome Rajendra Singh MD a global leader in Digital and Computational Pathology to our @PennPathLabMed @TheUSCAP @ASCP_Chicago @PennMedicine Dr. Singh is a world-renowned expert in both Dermatopathology and Digital Pathology/Artificial Intelligence. Dr. Singh received his MBBS from Baroda Medical College, Baroda, India. Dr. Singh was an Instructor and Blood Bank Director in the Department of Pathology at M.S. University in Baroda, India before becoming the Chief Pathologist at Jay Pathology Laboratories, Baroda, India. From 2010-2011 he was appointed Assistant Professor of Pathology and Dermatology at the University of Pittsburgh, Pittsburgh, PA after which he was recruited to Icahn School of Medicine at Mount Sinai, New York, NY in 2011 as an Assistant Professor. At Mount Sinai, he was the Dermatopathology Fellowship Director and the Associate Director of the Dermatopathology Section. He was promoted to Associate Professor in 2015 and to Professor in 2018. In August 2020, Dr. Singh was recruited as Professor of Pathology and Dermatology, Director of Dermatology and Associate Chair of Digital Pathology at Northwell Health in New York, NY where he stayed until November of 2021. He was most recently the Director of Dermatology and Digital Pathology at Summit Health in New Jersey.   Dr. Singh is the founder of Path Presenter, the world’s most widely adopted digital pathology education and collaboration platform. By integrating digital whole-slide imaging, structured case libraries, and AI-powered educational tools, the platform has revolutionized how pathology is taught, accessed, and practiced—particularly in underserved regions. A central focus of Dr. Singh’s work is expanding access to high-quality pathology education and diagnostics in low- and middle-income countries. His commitment to equity is not only technological but deeply personal driven by the belief that access to expert pathology should not be determined by geography.   Dr. Singh is an active member in the College of American Pathologists and in 2022, he received the CAP Lifetime Achievement Award. In addition, in 2025, Dr. Singh received the 2025 CAP Meritorious Service Award. Dr. Singh has also been recognized by the Pathologist magazine’s Power List in 2020, 2021, 2022, 2024 and 2025.

Great to work with my brilliant H&N path colleague @DioufaNikolina @PennPathLabMed @DrNetto @ktmontone @EndoPath rdcu.be/eVmFk

@ESP_Pathology @ASCP_Chicago @TheUSCAP @Sciencedirect @ElsevierConnect

Coming soon to Elsevier Publishing!

Plasma p-Tau217 and Amyloid Burden in Older Adults WITHOUT Cognitive Impairment : Plasma p-tau217 reliably detect AD pathology in the preclinical stage. findings support clinical utility of plasma p-tau217 as a minimally invasive tool for early identification of AD, particularly in settings where timely intervention with disease-modifying therapies may offer the greatest benefit in slowing or preventing disease progression. jamanetwork.com/journals/jaman…

Building Programs and People thepathologist.com/issues/2025/ar…